Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Life Science

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0024-3205(94)00732-2PMID 8028448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence from receptor antagonists of an important role for ETB receptor‐mediated vasoconstrictor effects of endothelin‐1 in the rat kidney

  1994cited by this paper
• J+ = J

  1994cited by this paper
• Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat

  1993cited by this paper
• Rat kidney endothelin receptors in ischemia-induced acute renal failure.

  1993cited by this paper
• Pathophysiology of experimental nonoliguric acute renal failure.

  1993cited by this paper
• Endothelin peptides and the kidney.

  1993cited by this paper
• Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats.

  1992cited by this paper
• The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo.

  1992cited by this paper
• Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.

  1992cited by this paper
• Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses.

  1992cited by this paper
• Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands.

  1992cited by this paper
• Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats.

  1992cited by this paper
• Localization of endothelin-1 (ET-1), ET-2, and ET-3, mouse VIC, and sarafotoxin S6b binding sites in mammalian heart and kidney.

  1991cited by this paper
• A role for endothelin in the maintenance of post‐ischaemic renal failure in the rat.

  1991cited by this paper
• Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.

  1990cited by this paper
• Pathophysiological role of endothelin in acute renal failure.

  1990cited by this paper
• Role of endothelin in cyclosporine-induced glomerular dysfunction.

  1990cited by this paper
• Endothelin receptors in cultured renal epithelial cells.

  1990cited by this paper
• Endothelin: a potent renal and systemic vasoconstrictor peptide.

  1989cited by this paper
• Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis.

  1989cited by this paper
• Outbreak of asthma associated with soybean dust.

  1989cited by this paper
• Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways.

  1989cited by this paper
• Glomerular actions of endothelin in vivo.

  1989cited by this paper
• Plasma endothelin levels in patients with acute renal failure.

  1989cited by this paper
• Theophylline in rats during maintenance phase of post-ischemic acute renal failure.

  1988cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Cellular calcium in ischemic acute renal failure: role of calcium entry blockers.

  1987cited by this paper
• Assay for calcium channels.

  1985cited by this paper
• Oxygen free radicals in ischemic acute renal failure in the rat.

  1984cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Endothelin receptors in GtoPdb v.2025.3

  2025cites this paper
• Endothelin receptors in GtoPdb v.2023.1

  2023cites this paper
• A new type of triploid fish derived from the diploid hybrid crucian carp (♀) × autotetraploid fish (♂)

  2021cites this paper
• Endothelin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• 14.11 – Vasoactive Substances as Mediators of Renal Injury

  2018cites this paper
• Preventive Role of Endothelin Antagonist on Kidney Ischemia: Reperfusion Injury in Male and Female Rats

  2015cites this paper
• Blockade of endothelin receptors with bosentan limits ischaemia/reperfusion-induced injury in rat ovaries.

  2013cites this paper
• Role of angiotensin and endothelin in testicular ischemia reperfusion injury

  2012cites this paper
• The Clinical Potential of Endothelin Receptor Antagonists in Cardiovascular Medicine

  2012cites this paper
• Vasoactive Substances As Mediators of Renal Injury

  2010cites this paper
• Tezosentan reduces the renal injury induced by abdominal aortic ischemia-reperfusion in rats.

  2009cites this paper
• CHAPTER 15 – Kinins and Endothelin

  2008cites this paper
• The Role of Na+/Ca2+ Exchanger in Endothelin‐1‐Aggravated Hypoxia/Reoxygenation‐Induced Injury in Renal Epithelial Cells

  2007cites this paper
• Sur quels paramètres hémodynamiques rénaux ou de la fonction rénale doit-on agir pour protéger le rein?

  2005cites this paper
• [Endothelial dysfunction in severe forms of acute renal failure. New approaches to pathogenetic therapy].

  2005cites this paper
• [On which renal haemodynamic and renal function parameters can we act to protect the kidney?].

  2005cites this paper
• Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist.

  2004cites this paper
• Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure.

  2004cites this paper
• Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist

  2004cites this paper
• Endothelin-1 Aggravates Hypoxia/Reoxygenationinduced Injury in Renal Epithelial Cells through the Activation of a Na+/Ca2+ Exchanger

  2004cites this paper
• Endothelin-receptor blockade mitigates the adverse effect of preretrieval warm ischemia on posttransplantation renal function in rats1

  2003cites this paper
• The effects of endothelin receptor blockade in the course of experimental postishaemic acute renal failure

  2002cites this paper
• New therapeutics that antagonize endothelin: promises and frustrations

  2002cites this paper
• Pharmacokinetic Interaction between TAK-044, a New Endothelin Antagonist, and Ciclosporin in Rats

  2002cites this paper
• Endothelin receptor blockade during hypothermic perfusion preservation mitigates the adverse effect of preretrieval warm ischemic injury on posttransplant glomerular filtration rate1

  2002cites this paper
• Disposition of TAK-044, a New Endothelin Antagonist, in Rats and Dogs

  2002cites this paper
• Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle.

  2001cites this paper
• Endothelins: vasoactive modulators of renal function in health and disease.

  2001cites this paper
• Amelioration of post-ischaemic renal injury by contralateral uninephrectomy: a role of endothelin-1.

  2001cites this paper
• Acute effects of endothelin-1 and TAK-044 (ET(A) and ET(B) receptor antagonist) in rats with dilated cardiomyopathy.

  2000cites this paper
• Effect of Endothelin Receptor Antagonist (TAK-044) on Autotransplanted Perfused Kidneys in Dogs

  2000cites this paper
• Endothelin-1 Initiates the Development of Vasospasm after Subarachnoid Haemorrhage Through Protein Kinase C Activation, but does not Contribute to Prolonged Vasospasm

  2000cites this paper
• Role of endothelin in the pathogenesis of acute renal failure.

  2000cites this paper
• Optimal route of administration of mixed endothelin receptor antagonist (TAK-044) in liver transplantation

  2000cites this paper
• Endothelin-receptor antagonists: current and future perspectives.

  2000cites this paper
• Different changes of endothelin-1 after reperfusion in a warm ischemia/reperfusion and transplantation model in pig liver.

  2000cites this paper
• Endothelin antagonists.

  1999cites this paper
• Die pharmakologische Blockade des Renin-Angiotensin-Systems in der Prävention des postischämischen akuten Nierenversagens*

  1999cites this paper
• Endothelin antagonist improves viability of liver grafts from non-heart-beating donors.

  1999cites this paper
• The endothelin receptor antagonist TAK-044 in the treatment of reperfusion injury in organ transplantation.

  1999cites this paper
• Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation.

  1999cites this paper
• Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors.

  1999cites this paper
• Endothelin receptor blockade attenuates air embolization-induced pulmonary hypertension in sheep.

  1999cites this paper
• Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use.

  1999cites this paper
• Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist.

  1999cites this paper
• Endocrinology of Cardiovascular Function

  1998cites this paper
• A bridge over troubled water . . . mixed water and electrolyte disorders

  1998cites this paper
• Modulation of endothelin and nitric oxide: A rational approach to improve canine hepatic microcirculation

  1998cites this paper
• Effects of the endothelin receptor antagonist TAK-044 on hepatocyte element alterations in the ischemic-reperfused liver in Beagle dogs.

  1998cites this paper
• Expression of endothelin-1 and effects of an endothelin receptor antagonist, TAK-044, at reperfusion after cold preservation in a canine lung transplantation model.

  1998cites this paper
• The Development of Specific Endothelin-Receptor Antagonists

  1998cites this paper
• Endothelin and Cardiovascular Function

  1998cites this paper
• Pathophysiological Role of Endothelin and Potential Therapeutic Targets for Receptor Antagonists

  1998cites this paper
• Occasional survey A bridge over troubled water . . . mixed water and electrolyte disorders

  1998cites this paper
• Cardiopulmonary indications for endothelin receptor antagonists: review of recent efficacy trials.

  1997cites this paper
• Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.

  1997cites this paper
• Inhibitory effects of TAK‐044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists

  1997cites this paper
• Hepatoprotective effect of the endothelin receptor antagonist TAK‐044 against ischemia‐reperfusion injury in the canine liver

  1997cites this paper
• Reduction of burn-induced gastric mucosal injury by an endothelin receptor antagonist in rats.

  1997cites this paper
• Hepatoprotective effect of a nonselective endothelin receptor antagonist (TAK-044) in the transplanted liver.

  1997cites this paper
• Endothelins in the normal and diseased kidney.

  1997cites this paper
• Endothelin-induced inositol phosphate formation in rat kidney. Studies on receptor subtypes, G-proteins and regulation during ontogenesis

  1996cites this paper
• BQ‐123, a specific endothelin (ETA) receptor antagonist, prevents ischemia‐reperfusion injury in kidney transplantation

  1996cites this paper
• Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans.

  1996cites this paper
• Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptors.

  1996cites this paper
• TAK-044: An Endothelin Receptor Antagonist

  1996cites this paper
• Predictive factors for acute renal failure in thoracic and thoracoabdominal aortic aneurysm surgery.

  1996cites this paper
• Endothelin receptors: Receptor classification, novel receptor antagonists, and potential therapeutic targets

  1996cites this paper
• Pharmacological characterization of cardiovascular responses induced by endothelin-1 in the perfused rat heart.

  1996cites this paper
• BQ-123, a specific endothelin (ETA) receptor antagonist, prevents ischemia-reperfusion injury in kidney transplantation

  1996cites this paper
• Endothelin receptor antagonism.

  1995cites this paper
• Chapter 10. Progress in the Development of Endothelin Receptor Antagonists

  1995cites this paper
• Pharmacology of a non‐selective ETA and ETB receptor antagonist, TAK‐044 and the inhibition of myocardial infarct size in rats

  1995cites this paper
• Endothelin and Renal Function: From Theory to Therapy

  1995cites this paper
• Endothelin Receptor Antagonists

  1994cites this paper